NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for RVPH

Based on 4 analysts offering 12 month price targets for Reviva Pharmaceuticals Holdings Inc

Min Forecast
$7.00+698.18%
Avg Forecast
$8.25+840.71%
Max Forecast
$11.00+1,154.28%

Should I buy or sell RVPH stock?

Based on 4 analysts offering ratings for Reviva Pharmaceuticals Holdings Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RVPH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RVPH as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their RVPH stock forecasts and price targets.

RVPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-24
lockedlocked$00.00+00.00%2025-01-22
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-10

1 of 1

Forecast return on equity

Is RVPH forecast to generate an efficient return?

Company
N/A
Industry
146.26%
Market
80.85%

Forecast return on assets

Is RVPH forecast to generate an efficient return on assets?

Company
N/A
Industry
36.38%

RVPH earnings per share forecast

What is RVPH's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.70
Avg 2 year Forecast
-$0.47

RVPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVPH$0.88$8.25+840.71%Strong Buy
BRNS$1.00$3.00+200.00%Buy
BLUE$4.12$25.75+525.00%Buy
STTK$0.83$4.00+381.35%Buy
VRCA$0.46$2.00+334.78%Hold

Reviva Pharmaceuticals Holdings Stock Forecast FAQ

Is Reviva Pharmaceuticals Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RVPH) stock is to Strong Buy RVPH stock.

Out of 4 analysts, 3 (75%) are recommending RVPH as a Strong Buy, 1 (25%) are recommending RVPH as a Buy, 0 (0%) are recommending RVPH as a Hold, 0 (0%) are recommending RVPH as a Sell, and 0 (0%) are recommending RVPH as a Strong Sell.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.

What is RVPH's earnings growth forecast for 2025-2026?

(NASDAQ: RVPH) Reviva Pharmaceuticals Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Reviva Pharmaceuticals Holdings's earnings in 2025 is -$29,918,802.On average, 3 Wall Street analysts forecast RVPH's earnings for 2025 to be -$32,717,964, with the lowest RVPH earnings forecast at -$38,326,758, and the highest RVPH earnings forecast at -$26,641,771.

In 2026, RVPH is forecast to generate -$21,967,776 in earnings, with the lowest earnings forecast at -$31,783,165 and the highest earnings forecast at -$12,152,387.

What is RVPH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RVPH) forecast ROE is N/A, which is considered weak.

What is RVPH's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RVPH price target, the average RVPH price target is $8.25, with the highest RVPH stock price forecast at $11.00 and the lowest RVPH stock price forecast at $7.00.

On average, Wall Street analysts predict that Reviva Pharmaceuticals Holdings's share price could reach $8.25 by Apr 24, 2026. The average Reviva Pharmaceuticals Holdings stock price prediction forecasts a potential upside of 840.71% from the current RVPH share price of $0.88.

What is RVPH's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: RVPH) Reviva Pharmaceuticals Holdings's current Earnings Per Share (EPS) is -$0.90. On average, analysts forecast that RVPH's EPS will be -$0.70 for 2025, with the lowest EPS forecast at -$0.82, and the highest EPS forecast at -$0.57. In 2026, RVPH's EPS is forecast to hit -$0.47 (min: -$0.68, max: -$0.26).

What is RVPH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RVPH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 36.38%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.